Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Surmodics Inc (SRDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,780
  • Shares Outstanding, K 13,200
  • Annual Sales, $ 73,110 K
  • Annual Income, $ 3,930 K
  • 36-Month Beta 0.85
  • Price/Sales 5.32
  • Price/Cash Flow 30.72
  • Price/Book 3.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.75 +8.97%
on 01/08/18
29.75 -2.02%
on 01/19/18
+0.30 (+1.04%)
since 12/22/17
3-Month
26.75 +8.97%
on 01/08/18
34.15 -14.64%
on 12/01/17
-1.80 (-5.82%)
since 10/20/17
52-Week
21.90 +33.11%
on 03/28/17
34.15 -14.64%
on 12/01/17
+4.75 (+19.47%)
since 01/20/17

Most Recent Stories

More News
Surmodics Receives 510(K) Clearance for Telemark(TM) Coronary/Peripheral Support Microcatheter from the U.S. Food and Drug Administration

--Proprietary Hydrophilic Coating Provides Best-in-Class Lubricity and Low Particulates

SRDX : 29.15 (-1.19%)
Surmodics (SRDX) Poised on Core Business Amid Forex Woes

Surmodics' (SRDX) top line benefits from strong sales in Medical Device and IVD businesses. However, foreign currency is a headwind.

ITGR : 49.75 (+1.43%)
SRDX : 29.15 (-1.19%)
BIO : 254.65 (+0.04%)
MDT : 86.05 (-0.73%)
New Strong Sell Stocks for January 8th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

PRIM : 26.28 (-0.19%)
SRDX : 29.15 (-1.19%)
CAMP : 23.13 (+0.09%)
INT : 28.66 (+1.96%)
BPL : 55.97 (+1.73%)
SurModics (SRDX) Posts Earnings in Q4, Revenues Top Estimates

SurModics' (SRDX) stellar fourth-quarter results benefit from higher product sales, royalties, research, development and other revenues.

PETS : 48.11 (-9.64%)
SRDX : 29.15 (-1.19%)
LMNX : 20.56 (unch)
ISRG : 433.94 (+0.16%)
Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 fourth quarter,...

SRDX : 29.15 (-1.19%)
Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief...

SRDX : 29.15 (-1.19%)
Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil(R) Drug-Coated Balloon

--Plan to enroll up to 446 patients at approximately 78 sites

SRDX : 29.15 (-1.19%)
MDT : 86.05 (-0.73%)
Surmodics Receives FDA's Approval for PTA Balloon Catheter

Surmodics (SRDX) receives FDA's approval for PTA Balloon Catheter, which will boost its presence in the global peripheral artery disease market.

EW : 124.51 (+0.48%)
SRDX : 29.15 (-1.19%)
LNTH : 23.20 (+1.75%)
IDXX : 180.95 (+0.18%)
Surmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation Catheter

Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced it has received U.S. Food and Drug Administration...

SRDX : 29.15 (-1.19%)
Surmodics Presents Encouraging SurVeil DCB Data at VIVA Meet

Surmodics' (SRDX) promising data on SurVeil DCB will boost its fortunes in the symptomatic peripheral artery disease space.

EW : 124.51 (+0.48%)
SRDX : 29.15 (-1.19%)
LNTH : 23.20 (+1.75%)
IDXX : 180.95 (+0.18%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Key Turning Points

2nd Resistance Point 29.91
1st Resistance Point 29.53
Last Price 29.15
1st Support Level 28.89
2nd Support Level 28.62

See More

52-Week High 34.15
Fibonacci 61.8% 29.47
Last Price 29.15
Fibonacci 50% 28.03
Fibonacci 38.2% 26.58
52-Week Low 21.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.